Now available, report your flu vaccine stock status (In Stock or Out of Stock) for display on Vaccines.gov through your COVID Locating Health Portal account. In the coming weeks, CDC’s National Flu Vaccination Campaign will be promoting Vaccines.gov as a source to find flu vaccines. Help ensure the public can find flu vaccines near them by updating your flu vaccine stock status by September 24, 2021.
Add vaccines: Select from the list of 2021–2022 flu vaccine NDCs and add them to your location(s) to update your stock status. The following flu vaccine categories will be displayed on Vaccines.gov:
-
Flu Shot: non-high dose quadrivalent shot NDCs (Afluria, FluLaval, and Fluzone) will be grouped together under the searchable name “Flu Shot.”
-
Flu Shot (egg-free): egg free NDCs (Flublock and Flucelvax) will be grouped together under the searchable name “Flu Shot (Egg Free).”
-
Flu Shot (65+, high-dose or adjuvanted): high-dose and adjuvanted NDCs (Fluzone High Dose and Fluad) will be grouped together under the searchable name “Flu Shot (65+, high-dose or adjuvanted).”
-
Flu Nasal Spray: FluMist nasal spray will be searchable under the name “Flu Nasal Spray.”
Display your location(s) on Vaccines.gov and update ‘In Stock’ status using the log manually or the file upload option.
-
Log manually: Toggle Display to the Public to On and then update the ‘In Stock’ status (Yes=In Stock, No=Out of Stock).
-
File upload: Download a blank file template with location(s) and update the In Stock column (Yes=In Stock, No=Out of Stock).
Update stock status every 2 weeks. Location(s) set to display to the public that have not updated their stock status in 2 weeks will show as “Call to Confirm” for each flu vaccine.
Co-administration of COVID-19 and Influenza Vaccines
Also, you may administer COVID-19 and influenza vaccines without regard to timing (both live, attenuated and non-live influenza vaccines). This includes administration of COVID-19 and influenza vaccines on the same day, as well as co-administration at any time interval.
With influenza season approaching, CDC recognizes there may be compelling logistical advantages to offering patients COVID-19 and influenza vaccines on the same day and is encouraged. There are no safety concerns for co-administration.
When deciding whether to co-administer other vaccine(s) with COVID-19 vaccine, consider:
-
Whether the patient is behind or at risk of becoming behind on recommended vaccines
- The patient’s risk of vaccine-preventable disease
- The reactogenicity profile of the vaccines
- The likelihood of avoiding a missed opportunity to vaccinate
Best practices for multiple injections include:
-
Label each syringe with the name and the dosage (amount) of the vaccine, lot number, the initials of the preparer, and the exact beyond-use time, if applicable.
- Separate injection sites by 1 inch or more, if possible.
- Administer the COVID-19 vaccines and vaccines that may be more likely to cause a local reaction (i.e., adjuvanted influenza vaccines) in different limbs, if possible.
Thank you for your efforts in keeping Oklahomans safe from Influenza and COVID-19!
|
|
